YARNOLD; Christopher John

Patent Applications and Registrations

Patent applications and USPTO patent grants for YARNOLD; Christopher John.The latest application filed is for "histone acetyltransferase modulators and compositions and uses thereof".

Company Profile

8.15.19

YARNOLD; Christopher John - Abingdon Oxfordshire
Yarnold; Christopher John - Didcot Oxon GB
Yarnold; Christopher John - Oxfordshire N/A GB
Yarnold; Christopher John - Didcot GB
Yarnold; Christopher John - Oxon GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Histone Acetyltransferase Modulators And Compositions And Uses Thereof App 20220127232 - ARANCIO; Ottavio ; et al.	2022-04-28
Antiviral compounds Grant 11,180,479 - Fischl , et al. November 23, 2	2021-11-23
Antiviral compounds Grant 11,091,428 - Fischl , et al. August 17, 2	2021-08-17
Ferroportin inhibitors Grant 11,066,399 - Durrenberger , et al. July 20, 2	2021-07-20
Novel Ferroportin Inhibitors App 20210139472 - Durrenberger; Franz ; et al.	2021-05-13
Ferroportin inhibitors Grant 11,001,579 - Durrenberger , et al. May 11, 2	2021-05-11
Ferroportin inhibitors Grant 10,738,041 - Durrenberger , et al. A	2020-08-11
Antiviral Compounds App 20200239446 - FISCHL; Wolfgang ; et al.	2020-07-30
Novel Ferroportin Inhibitors App 20190345151 - Durrenberger; Franz ; et al.	2019-11-14
Ferroportin inhibitors Grant 10,364,239 - Durrenberger , et al.	2019-07-30
Antiviral Compounds App 20190225575 - Fischl; Wolfgang ; et al.	2019-07-25
Novel Ferroportin Inhibitors App 20180319783 - Durrenberger; Franz ; et al.	2018-11-08
Novel Ferroportin Inhibitors App 20180297991 - Durrenberger; Franz ; et al.	2018-10-18
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 9,145,373 - Wityak , et al. September 29, 2	2015-09-29
Transglutaminase Tg2 Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20150232420 - Dominguez; Celia ; et al.	2015-08-20
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 8,691,824 - Wityak , et al. April 8, 2	2014-04-08
Certain Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20130331370 - Wityak; John ; et al.	2013-12-12
Quinazolin-oxime derivatives as Hsp90 inhibitors Grant 8,592,430 - Courtney , et al. November 26, 2	2013-11-26
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 8,536,186 - Wityak , et al. September 17, 2	2013-09-17
Certain Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20120329812 - Wityak; John ; et al.	2012-12-27
Certain Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20110230428 - Wityak; John ; et al.	2011-09-22
Certain Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20110183957 - Wityak; John ; et al.	2011-07-28
Quinazolin-oxime Derivatives As Hsp90 Inhibitors App 20110118258 - Courtney; Stephen Martin ; et al.	2011-05-19
Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT Grant 7,915,304 - Pellicci , et al. March 29, 2	2011-03-29
Phenyl Substituted Maleimides As Medicaments For Blocking Degenerative Tissue Damages By Inhibiting Mpt App 20100099736 - Pellicci; PierGiuseppe ; et al.	2010-04-22
Pyrazine Derivatives As Effective Compounds Against Infectious Diseases App 20080194574 - Eikhoff; Jan Eike ; et al.	2008-08-14
Carboline and betacarboline derivatives for use as hdac enzyme inhibitors App 20060235012 - Davidson; Alan Hornsby ; et al.	2006-10-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.